Elligo Health Research, an Austin, TX-based provider of a technology platform for clinical research, received a $40M venture loan facility from Horizon Technology Finance (NASDAQ: HRZN).
The company intends to use the loan proceeds for general growth and working capital purposes.
Led by John Potthoff, Ph.D., Founder and CEO, Elligo Health Research accelerates clinical trials through direct access to known, diverse patients from more than 115 hospitals and major health systems, 200 healthcare-based sites, and 100 research-based sites, leveraging EHR data and utilizing our proprietary IntElligo technology. Its PatientSelect® model engages networks to optimize the intersection of healthcare and research and bring more patients clinical research as a care option and its SiteSelect model and Research Partner Services enable sites to participate in trials, further advancing the development of new pharmaceutical, biotechnology, and medical device and diagnostic products.
Elligo is backed by investors including Morgan Stanley, Ally Bridge Group, Norwest Venture Partners, Piper Sandler, Noro-Moseley Partners and Hatteras Venture Partners.
FinSMEs
02/10/2023